Doctor profile · Federal record

Dr. Daya Sharma, MD

Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Medical Oncology Physician · Silver Spring, MD

  • NPI 1871527937
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 51 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
10750 Columbia Pike Ste 501
Silver Spring, MD 209014460
(301) 593-9035
fax (301) 593-9036
Mailing address
Po Box 749488
Atlanta, GA 303749488

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
January 3, 2023
Year of graduation
1975 — 51 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (2)
Maryland #D0041119 · District of Columbia #MD20082
Medicaid (2)
MD #229991700 · DC #035146100

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1871527937. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
94,337
Distinct HCPCS
10
Medicare allowed
$1,623,589
HCPCS Description Services Patients Avg allowed
J9299 Injection, nivolumab, 1 mg 31,600 12 $30
J1756 Injection, iron sucrose, 1 mg 17,400 29 $0
J9041 Injection, bortezomib, 0.1 mg 11,061 17 $5
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 11,040 42 $7
J0897 Injection, denosumab, 1 mg 5,280 19 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,672 33 $0
J2469 Injection, palonosetron hcl, 25 mcg 3,830 42 $1
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,786 23 $0
J1437 Injection, ferric derisomaltose, 10 mg 1,600 15 $19
99213 Established patient office or other outpatient visit, 20-29 minutes 946 297 $102

In context: peer comparison

Among 1 peers in this city , average services per provider: 2,695. This provider delivers 35× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$6,723
Transactions
105
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 15 $2,600.61
Novartis Pharmaceuticals Corporation 18 $1,189.05
Daiichi Sankyo Inc. 11 $737.43
Janssen Biotech, Inc. 11 $286.20
ABBVIE INC. 8 $235.26
Merck Sharp & Dohme LLC 9 $200.65
PFIZER INC. 8 $185.29
Incyte Corporation 3 $129.99
E.R. Squibb & Sons, L.L.C. 5 $112.66
Takeda Pharmaceuticals U.S.A., Inc. 4 $103.73
Exelixis Inc. 3 $94.62
Celgene Corporation 3 $86.66
GlaxoSmithKline, LLC. 3 $67.46
Mirati Therapeutics, Inc. 2 $55.49
TAIHO ONCOLOGY, INC. 2 $53.05

By nature of payment

Food and Beverage
$2,855
Consulting Fee
$2,450
Long term medical supply or device loan
$997
Travel and Lodging
$337
Education
$84

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
659
Patients
72
Total drug cost
$2,738,813
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 98 19 $64,800
Xtandi (Enzalutamide) Brand 75 11 $1,108,603
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 73 0 $883
Oxycodone Hcl Generic 67 20 $936
Letrozole Generic 46 0 $1,271
Xarelto (Rivaroxaban) Brand 43 0 $45,780
Ibrance (Palbociclib) Brand 42 0 $577,412
Warfarin Sodium Generic 42 11 $754
Hydrocortisone Generic 34 0 $1,231
Lupron Depot (Leuprolide Acetate) Brand 31 11 $88,775

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Daya Sharma's medical specialty?
Dr. Daya Sharma practices Medical Oncology Physician in Silver Spring, MD.
Where does Dr. Daya Sharma practice?
Dr. Daya Sharma practices at 10750 Columbia Pike Ste 501, Silver Spring, MD 209014460. Office phone: 3015939035.
What is Dr. Daya Sharma's NPI?
Dr. Daya Sharma's National Provider Identifier (NPI) is 1871527937, issued by NPPES.
Does Dr. Daya Sharma accept Medicare assignment?
Yes. Dr. Daya Sharma accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daya Sharma commonly perform?
Top Medicare-reported procedures in 2023: Injection, nivolumab, 1 mg (HCPCS J9299); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, bortezomib, 0.1 mg (HCPCS J9041). Source: CMS Medicare Physician & Other Practitioners file.